{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T02:49:25Z","timestamp":1790045365892,"version":"4.0.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T00:00:00Z","timestamp":1516233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacionline.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Allergy and Clinical Immunology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/j.jaci.2017.11.050","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T05:15:03Z","timestamp":1517375703000},"page":"904-913.e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"title":["T-cell gene therapy for perforin deficiency corrects\u00a0cytotoxicity defects and prevents hemophagocytic lymphohistiocytosis manifestations"],"prefix":"10.1016","volume":"142","author":[{"given":"Sujal","family":"Ghosh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marlene","family":"Carmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Calero-Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5780-6580","authenticated-orcid":false,"given":"Ida","family":"Ricciardelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3409-6226","authenticated-orcid":false,"given":"Juan Carlos","family":"Bustamante Ogando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael P.","family":"Blundell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Schambach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip G.","family":"Ashton-Rickardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire","family":"Booth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Ehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai","family":"Lehmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian J.","family":"Thrasher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H. Bobby","family":"Gaspar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jaci.2017.11.050_bib1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1146\/annurev-med-041610-134208","article-title":"Familial and acquired hemophagocytic lymphohistiocytosis","volume":"63","author":"Janka","year":"2012","journal-title":"Annu Rev Med"},{"key":"10.1016\/j.jaci.2017.11.050_bib2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1365-2249.2010.04302.x","article-title":"Familial haemophagocytic lymphohistiocytosis: advances in the genetic basis, diagnosis and management","volume":"163","author":"Gholam","year":"2011","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/j.jaci.2017.11.050_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1097\/MOP.0b013e32834ec9c1","article-title":"Hemophagocytic lymphohistiocytosis: updates and evolving concepts","volume":"24","author":"Risma","year":"2012","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/j.jaci.2017.11.050_bib4","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1126\/science.286.5446.1957","article-title":"Perforin gene defects in familial hemophagocytic lymphohistiocytosis","volume":"286","author":"Stepp","year":"1999","journal-title":"Science"},{"key":"10.1016\/j.jaci.2017.11.050_bib5","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2141.2004.05305.x","article-title":"Perforin and lymphohistiocytic proliferative disorders","volume":"128","author":"Katano","year":"2005","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaci.2017.11.050_bib6","doi-asserted-by":"crossref","first-page":"e622","DOI":"10.1542\/peds.2006-3164","article-title":"Immunotherapy of familial hemophagocytic lymphohistiocytosis with antithymocyte globulins: a single-center retrospective report of 38 patients","volume":"120","author":"Mahlaoui","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/j.jaci.2017.11.050_bib7","doi-asserted-by":"crossref","first-page":"4041","DOI":"10.1182\/blood-2011-03-278127","article-title":"How I treat hemophagocytic lymphohistiocytosis","volume":"118","author":"Jordan","year":"2011","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2017.11.050_bib8","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter","year":"2007","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jaci.2017.11.050_bib9","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1182\/blood-2002-01-0172","article-title":"Treatment of hemophagocytic lymphohistiocytosis with HLH-94 immunochemotherapy and bone marrow transplantation","volume":"100","author":"Henter","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2017.11.050_bib10","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1002\/pbc.24188","article-title":"Salvage therapy of refractory hemophagocytic lymphohistiocytosis with alemtuzumab","volume":"60","author":"Marsh","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jaci.2017.11.050_bib11","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1016\/j.hoc.2015.06.011","article-title":"The role of hematopoietic stem cell transplantation in treatment of hemophagocytic lymphohistiocytosis","volume":"29","author":"Nikiforow","year":"2015","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/j.jaci.2017.11.050_bib12","doi-asserted-by":"crossref","first-page":"5824","DOI":"10.1182\/blood-2010-04-282392","article-title":"Reduced-intensity conditioning significantly improves survival of patients with hemophagocytic lymphohistiocytosis undergoing allogeneic hematopoietic cell transplantation","volume":"116","author":"Marsh","year":"2010","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2017.11.050_bib13","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3324\/haematol.2013.094730","article-title":"Treosulfan-based conditioning regimen for children and adolescents with hemophagocytic lymphohistiocytosis","volume":"99","author":"Lehmberg","year":"2014","journal-title":"Haematologica"},{"key":"10.1016\/j.jaci.2017.11.050_bib14","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1182\/blood-2003-10-3413","article-title":"An animal model of hemophagocytic lymphohistiocytosis (HLH): CD8+ T cells and interferon gamma are essential for the disorder","volume":"104","author":"Jordan","year":"2004","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2017.11.050_bib15","doi-asserted-by":"crossref","first-page":"2618","DOI":"10.1182\/blood-2013-06-508143","article-title":"Mixed hematopoietic or T-cell chimerism above a minimal threshold restores perforin-dependent immune regulation in perforin-deficient mice","volume":"122","author":"Terrell","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2017.11.050_bib16","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1038\/mt.2014.242","article-title":"Perforin gene transfer into hematopoietic stem cells improves immune dysregulation in murine models of perforin deficiency","volume":"23","author":"Carmo","year":"2015","journal-title":"Mol Ther"},{"key":"10.1016\/j.jaci.2017.11.050_bib17","doi-asserted-by":"crossref","first-page":"5184","DOI":"10.1182\/blood-2013-04-495309","article-title":"Perforin deficiency impairs a critical immunoregulatory loop involving murine CD8(+) T cells and dendritic cells","volume":"121","author":"Terrell","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2017.11.050_bib18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1006\/mthe.2000.0191","article-title":"Context dependence of different modules for posttranscriptional enhancement of gene expression from retroviral vectors","volume":"2","author":"Schambach","year":"2000","journal-title":"Mol Ther"},{"key":"10.1016\/j.jaci.2017.11.050_bib19","doi-asserted-by":"crossref","first-page":"3645","DOI":"10.4049\/jimmunol.164.7.3645","article-title":"Crucial role of TNF-alpha in CD8 T cell-mediated elimination of 3LL-A9 Lewis lung carcinoma cells in\u00a0vivo","volume":"164","author":"Prevost-Blondel","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2017.11.050_bib20","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1038\/nm.1982","article-title":"Wnt signaling arrests effector T cell differentiation and generates CD8+ memory stem cells","volume":"15","author":"Gattinoni","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/j.jaci.2017.11.050_bib21","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1111\/j.1365-2141.2011.08785.x","article-title":"Reduced-intensity conditioning haematopoietic cell transplantation for haemophagocytic lymphohistiocytosis: an important step forward","volume":"154","author":"Marsh","year":"2011","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jaci.2017.11.050_bib22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/emmm.200900009","article-title":"Neutralization of IFNgamma defeats haemophagocytosis in LCMV-infected perforin- and Rab27a-deficient mice","volume":"1","author":"Pachlopnik Schmid","year":"2009","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.jaci.2017.11.050_bib23","doi-asserted-by":"crossref","first-page":"1666","DOI":"10.1182\/blood-2015-12-684399","article-title":"Janus kinase inhibition lessens inflammation and ameliorates disease in murine models of hemophagocytic lymphohistiocytosis","volume":"127","author":"Das","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2017.11.050_bib24","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1182\/blood-2016-02-700013","article-title":"Therapeutic effect of JAK1\/2 blockade on the manifestations of hemophagocytic lymphohistiocytosis in mice","volume":"128","author":"Maschalidi","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2017.11.050_bib25","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1182\/blood-2015-07-659813","article-title":"ST2 contributes to T-cell hyperactivation and fatal hemophagocytic lymphohistiocytosis in mice","volume":"127","author":"Rood","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2017.11.050_bib26","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4049\/jimmunol.1302282","article-title":"Etoposide selectively ablates activated T cells to control the immunoregulatory disorder hemophagocytic lymphohistiocytosis","volume":"192","author":"Johnson","year":"2014","journal-title":"J Immunol"},{"key":"10.1016\/j.jaci.2017.11.050_bib27","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.1182\/blood-2015-12-684498","article-title":"The minimum required level of donor chimerism in hereditary hemophagocytic lymphohistiocytosis","volume":"127","author":"Hartz","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jaci.2017.11.050_bib28","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1001\/jama.2015.3253","article-title":"Outcomes following gene therapy in patients with severe Wiskott-Aldrich syndrome","volume":"313","author":"Hacein-Bey Abina","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/j.jaci.2017.11.050_bib29","doi-asserted-by":"crossref","first-page":"1233158","DOI":"10.1126\/science.1233158","article-title":"Lentiviral hematopoietic stem cell gene therapy benefits metachromatic leukodystrophy","volume":"341","author":"Biffi","year":"2013","journal-title":"Science"},{"key":"10.1016\/j.jaci.2017.11.050_bib30","unstructured":"Bartholomae C, Cartier N, Hacein-Bey Abina S, Kutschera I, Fischer A, Cavazzana M, et\u00a0al. Long-term follow-up of lentiviral integration profiles from patients undergoing clinical gene therapy for X-adrenoleukodystrophy. Presented at: American Society of Gene & Cell Therapy, 17th Annual Meeting; Washington, DC; 2014."},{"key":"10.1016\/j.jaci.2017.11.050_bib31","series-title":"Improving gene therapy for beta-thalassemia major: initial results from study Hgb-205","author":"Cavazzana","year":"2014"},{"key":"10.1016\/j.jaci.2017.11.050_bib32","unstructured":"Gaspar HB, Buckland K, Rivat C, Himoudi N, Gilmour K, Booth C, et\u00a0al. Immunological and metabolic correction after lentiviral vector mediated haematopoietic stem cell gene therapy for ADA deficiency. Presented at: American Society of Gene & Cell Therapy, 17th Annual Meeting; Washington, DC; 2014."},{"key":"10.1016\/j.jaci.2017.11.050_bib33","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1404588","article-title":"A modified gamma-retrovirus vector for X-linked severe combined immunodeficiency","volume":"371","author":"Hacein-Bey-Abina","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jaci.2017.11.050_bib34","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/S0140-6736(14)61403-3","article-title":"T cells expressing CD19 chimeric antigen receptors for acute lymphoblastic leukaemia in children and young adults: a phase 1 dose-escalation trial","volume":"385","author":"Lee","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/j.jaci.2017.11.050_bib35","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1056\/NEJMoa1407222","article-title":"Chimeric antigen receptor T cells for sustained remissions in leukemia","volume":"371","author":"Maude","year":"2014","journal-title":"N Engl J Med"}],"container-title":["Journal of Allergy and Clinical Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918300757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0091674918300757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T09:11:52Z","timestamp":1758791512000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0091674918300757"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S0091674918300757"],"URL":"https:\/\/doi.org\/10.1016\/j.jaci.2017.11.050","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732538483.793572309","asserted-by":"object"}]},"ISSN":["0091-6749"],"issn-type":[{"value":"0091-6749","type":"print"}],"subject":[],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"T-cell gene therapy for perforin deficiency corrects\u00a0cytotoxicity defects and prevents hemophagocytic lymphohistiocytosis manifestations","name":"articletitle","label":"Article Title"},{"value":"Journal of Allergy and Clinical Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jaci.2017.11.050","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.","name":"copyright","label":"Copyright"}]}}